unc-112 Antibody

What are the primary research applications for UNC-112 antibodies in C. elegans studies?

UNC-112 antibodies serve as essential tools for investigating integrin adhesion complexes in C. elegans muscle. They enable visualization of UNC-112 localization at muscle attachment structures through immunofluorescence microscopy, detection of expression levels via western blotting, and characterization of protein-protein interactions (particularly with PAT-3 and PAT-4) through co-immunoprecipitation. When designing experiments, antibody specificity should be validated using unc-112 mutants as negative controls and recombinant UNC-112 protein as positive controls. These approaches are particularly valuable for studying the molecular mechanisms underlying muscle development and maintenance, as UNC-112 functions as a core component within integrin adhesion complexes .

What fixation protocols optimize UNC-112 antibody performance in C. elegans muscle tissue?

For optimal UNC-112 immunostaining in C. elegans muscle tissue, a sequential fixation approach is recommended. Begin with 4% paraformaldehyde fixation (10-15 minutes at room temperature), followed by methanol fixation (-20°C for 5 minutes) to better preserve muscle ultrastructure. Permeabilize specimens using the freeze-crack method on dry ice after mounting in buffer on poly-L-lysine coated slides. Further enhance antibody penetration by incubating in PBS containing 0.5% Triton X-100 for 30 minutes. This protocol preserves the integrity of dense muscle attachment structures while providing sufficient permeabilization for antibody access to the integrin adhesion complexes where UNC-112 resides .

How do UNC-112 antibody staining patterns correlate with mutant phenotypes?

UNC-112 antibody staining patterns directly correlate with functional defects observed in unc-112 mutants. In wild-type C. elegans, UNC-112 antibodies reveal a highly organized, striated pattern at muscle cell boundaries and M-lines, reflecting its role in integrin adhesion complexes. In partial loss-of-function mutants like unc-112(r367) (T85I), antibody staining shows disrupted localization patterns with reduced intensity and discontinuous distribution at attachment structures, corresponding to the embryonic lethal or uncoordinated (Unc) movement phenotypes . The degree of disorganization in UNC-112 localization correlates with the severity of muscle detachment and functional impairment, making antibody staining a valuable phenotypic readout for novel alleles .

How can UNC-112 antibodies be used to investigate the conformational change from "closed" to "open" state upon PAT-4 binding?

To study UNC-112's conformational change upon PAT-4 binding, researchers can employ conformation-specific antibodies that recognize epitopes exposed only in the open or closed configuration. Previous research has demonstrated that UNC-112 binds directly to the cytoplasmic tail of PAT-3 and that the N- and C-terminal halves of UNC-112 bind to each other . Furthermore, PAT-4 binding to UNC-112 can compete with this intramolecular interaction, changing UNC-112 from a closed (inactive) to open (active) state . For detailed analysis, implement Förster Resonance Energy Transfer (FRET) using N- and C-terminal-specific UNC-112 antibodies labeled with appropriate fluorophore pairs; decreased FRET efficiency would indicate conformational opening when PAT-4 binds. Limited proteolysis protection assays can also reveal differential digestion patterns between PAT-4-bound and unbound UNC-112, detectable via western blotting with domain-specific antibodies.

What approaches can resolve contradictory co-immunoprecipitation data when studying UNC-112/PAT-4 interactions?

To resolve contradictory co-immunoprecipitation results for UNC-112/PAT-4 interactions, implement a systematic troubleshooting framework testing multiple variables:

This approach is particularly valuable when working with the PAT-4 mutants (Q308H, I432F, M464V) that cannot bind to UNC-112 and their corresponding UNC-112 suppressor mutants that restore interaction .

How can super-resolution microscopy with UNC-112 antibodies map precise spatial relationships in integrin complexes?

For super-resolution microscopy of UNC-112 within integrin adhesion complexes, directly label primary antibodies with photoswitchable fluorophores (Alexa Fluor 647, ATTO dyes) for STORM/PALM techniques, or use dyes with appropriate depletion properties (ATTO 647N) for STED microscopy. Implement two-color imaging with PAT-4 or PAT-3 antibodies to precisely map relative positions between complex components. Optimize sample preparation with smaller fixatives like glutaraldehyde and consider expansion microscopy protocols to physically enlarge specimens for improved resolution. This approach can reveal the nanoscale organization of UNC-112, PAT-4 and PAT-3 at muscle attachment structures, providing insights into how mutations affect complex assembly .

How should experiments be designed to distinguish between direct and indirect UNC-112 protein interactions?

To differentiate between direct and indirect UNC-112 interactions, implement a multi-tiered experimental design:

• Begin with sequential co-immunoprecipitation, where primary UNC-112 immunoprecipitates are denatured and subjected to a second round of immunoprecipitation with antibodies against suspected partners

• Perform in vitro binding assays with purified recombinant proteins to validate direct interactions

• Use proximity ligation assays in fixed tissues to visualize potential direct interactions (signals only generated when proteins are within 40nm)

• Employ FRET analysis with fluorophore-conjugated antibodies to assess nanometer-scale proximity

• Validate findings through genetic studies using the characterized UNC-112 and PAT-4 mutants that cannot bind each other, such as the PAT-4 mutants (Q308H, I432F) that fail to bind UNC-112

This integrated approach can effectively establish the direct binding partners of UNC-112 within the integrin adhesion complex.

What experimental approaches can determine if UNC-112 phosphorylation affects its interactions with PAT-4 and PAT-3?

To investigate how UNC-112 phosphorylation affects its interactions with PAT-4 and PAT-3, develop phospho-specific antibodies targeting predicted phosphorylation sites in UNC-112, particularly within FERM domains. Perform phosphorylation site mapping using mass spectrometry combined with immunoprecipitation. Generate phosphomimetic (S/T to D/E) and phospho-dead (S/T to A) UNC-112 mutants and assess their binding to PAT-4 and PAT-3 using co-immunoprecipitation with specific antibodies. Examine localization patterns of phospho-UNC-112 versus total UNC-112 in relation to PAT-3 and PAT-4 using immunofluorescence. This is particularly relevant since research has shown that PAT-4 binding to UNC-112 changes UNC-112's conformation from closed to open, enabling its interaction with PAT-3 .

How can pulse-chase experiments with UNC-112 antibodies track protein turnover at muscle attachment sites?

For tracking UNC-112 turnover at muscle attachment sites, establish a dual-labeling system using transgenic worms expressing UNC-112 with both a SNAP-tag and a conventional epitope tag. Pulse-label the SNAP-tag with cell-permeable fluorescent substrates, then chase for varying durations (0-72 hours) before fixation. Detect the total UNC-112 population via conventional antibody staining of the epitope tag with a spectrally distinct fluorophore. Calculate turnover rates by measuring the ratio of pulse signal (original population) to total UNC-112 signal across timepoints. Include controls with protein synthesis inhibitors to differentiate between protein degradation and dilution through new synthesis. This approach provides insights into the dynamic nature of integrin adhesion complexes and how mutations in complex components might affect protein stability .

How can researchers interpret contradictory results between UNC-112 antibody staining and UNC-112::GFP fusion localization?

When facing contradictions between UNC-112 antibody staining and UNC-112::GFP localization patterns, systematically evaluate several potential factors:

• Antibody specificity: Confirm using western blots comparing wild-type and unc-112 mutant lysates

• Epitope masking: Consider whether native protein context affects antibody accessibility in specific subcellular regions

• Tag interference: Assess whether the GFP tag disrupts protein folding, interactions, or targeting by comparing N-terminal versus C-terminal tagged versions

• Fusion protein functionality: Validate through rescue experiments in unc-112 mutant backgrounds

• Developmental dynamics: Determine if differences occur at specific developmental stages

• Fixation artifacts: Compare multiple fixation protocols with live imaging results

These investigations are particularly relevant when studying the interactions between UNC-112, PAT-4, and PAT-3, as subtle changes in protein conformation or complex assembly might be detected differently by antibodies versus GFP fusions .

What statistical approaches best analyze variability in UNC-112 localization patterns?

For analyzing variability in UNC-112 antibody staining patterns, implement quantitative image analysis workflows using platforms like ImageJ/Fiji with custom macros for consistent measurement of signal intensity, distribution patterns, and co-localization parameters. Extract multiple measurements including Pearson's correlation coefficients for co-localization with known partners like PAT-4, integrated intensity measurements, and spatial distribution metrics. Use nested statistical designs that account for multiple measurements from individual worms and multiple worms per condition. Apply mixed-effects models incorporating both fixed effects (genotype, treatment) and random effects (experimental variables). This approach is particularly valuable when comparing wild-type UNC-112 localization with that of mutant proteins or when examining how PAT-4 mutations affect UNC-112 distribution .

How can genetic suppressor data be integrated with UNC-112 antibody studies to model integrin complex assembly?

To integrate UNC-112 genetic suppressor data with antibody studies for modeling integrin complex assembly:

• Create quantitative datasets combining antibody-based protein localization measurements with phenotypic severity scores from corresponding genetic perturbations

• Implement hierarchical clustering analyses to identify patterns correlating protein mislocalization with functional defects

• Develop models of complex assembly pathways consistent with both genetic dependencies and protein localization dynamics

• Use temporal analysis of protein recruitment during development to establish assembly order

• Apply the insights from suppressor pairs, such as the PAT-4 mutants (I432F) that cannot bind UNC-112 and their UNC-112 suppressor mutants (F301S) that restore interaction

This integrated approach leverages both genetic and biochemical data to build comprehensive models of how the UNC-112/PAT-4 complex forms and functions within integrin adhesion sites.

How can UNC-112 antibodies be used to study mechanotransduction at muscle attachment sites?

For studying mechanotransduction using UNC-112 antibodies, implement mechanical stress paradigms (acute stretch, chronic exercise, paralytic drugs) while monitoring UNC-112 localization and complex formation. Include appropriate controls: time-matched unstressed specimens processed simultaneously and transgenic lines expressing UNC-112::fluorescent protein fusions as complementary readouts. Perform quantitative image analysis measuring changes in intensity, distribution patterns, and co-localization with mechanosensitive markers. Use sequential extraction protocols to distinguish changes in soluble versus cytoskeletal-bound UNC-112 fractions. This approach can reveal how mechanical forces regulate the interactions between UNC-112, PAT-4, and other components of the integrin adhesion complex, providing insights into mechanotransduction mechanisms in muscle cells .

What are the most effective approaches for using UNC-112 antibodies in CRISPR-engineered C. elegans strains?

When working with CRISPR-engineered C. elegans strains, carefully validate antibody recognition of modified UNC-112 proteins, particularly when mutations are near antibody epitopes. For strains with tagged UNC-112 variants (such as the unc-112(kq715) L715E allele created by CRISPR/Cas9 ), compare antibody staining patterns with intrinsic tag fluorescence to confirm concordance. When studying UNC-112/PAT-4 interaction mutants and suppressors, use antibodies to verify protein expression levels and stability before attributing phenotypes to binding defects. For quantitative studies of UNC-112 dynamics in CRISPR-modified backgrounds, implement FRAP (Fluorescence Recovery After Photobleaching) combined with antibody staining at fixed timepoints to correlate mobile fractions with complex assembly status.